- Home
- Publications
- Publication Search
- Publication Details
Title
An update on NMDA antagonists in depression
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume -, Issue -, Pages 1-13
Publisher
Informa UK Limited
Online
2019-07-22
DOI
10.1080/14737175.2019.1643237
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- (2R,6R)-hydroxynorketamine exerts mGlu2receptor-dependent antidepressant actions
- (2019) Panos Zanos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function
- (2019) Eric W. Lumsden et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- The glycine site of NMDA receptors: A target for cognitive enhancement in psychiatric disorders
- (2019) Bahareh Peyrovian et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Common Neurotransmission Recruited in ( R , S )-Ketamine and (2 R ,6 R )-Hydroxynorketamine–Induced Sustained Antidepressant-like Effects
- (2018) Thu Ha Pham et al. BIOLOGICAL PSYCHIATRY
- Mechanistic Target of Rapamycin–Independent Antidepressant Effects of ( R )-Ketamine in a Social Defeat Stress Model
- (2018) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- AMPA Receptor Activation–Independent Antidepressant Actions of Ketamine Metabolite ( S )-Norketamine
- (2018) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- What Are the Causes for Discrepancies of Antidepressant Actions of (2 R ,6 R )-Hydroxynorketamine?
- (2018) Kenji Hashimoto et al. BIOLOGICAL PSYCHIATRY
- Convergent Mechanisms Underlying Rapid Antidepressant Action
- (2018) Panos Zanos et al. CNS DRUGS
- The role of memantine in the treatment of major depressive disorder: Clinical efficacy and mechanisms of action
- (2018) Meysam Amidfar et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mechanisms of ketamine action as an antidepressant
- (2018) P Zanos et al. MOLECULAR PSYCHIATRY
- Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert
- (2018) Andreas Reiner et al. NEURON
- (2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray
- (2018) Dylan Chou et al. NEUROPHARMACOLOGY
- (2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice
- (2018) Jun-ichi Yamaguchi et al. NEUROPSYCHOPHARMACOLOGY
- Downregulation of Egr-1 Expression Level via GluN2B Underlies the Antidepressant Effects of Ketamine in a Chronic Unpredictable Stress Animal Model of Depression
- (2018) Wei-jie Zhang et al. NEUROSCIENCE
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy
- (2018) Allie J. Widman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Signaling pathways responsible for the rapid antidepressant-like effects of a GluN2A-preferring NMDA receptor antagonist
- (2018) Marta Gordillo-Salas et al. Translational Psychiatry
- Ketamine blocks bursting in the lateral habenula to rapidly relieve depression
- (2018) Yan Yang et al. NATURE
- Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model
- (2018) Kai Zhang et al. PSYCHOPHARMACOLOGY
- Rapastinel - an investigational NMDA-R modulator for major depressive disorder: evidence to date
- (2018) Renee-Marie Ragguett et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
- (2018) Bashkim Kadriu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine
- (2018) Kenichi Fukumoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hyperforin Potentiates Antidepressant-Like Activity of Lanicemine in Mice
- (2018) Bartłomiej Pochwat et al. Frontiers in Molecular Neuroscience
- Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
- (2017) Yukihiko Shirayama et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Role of NMDA receptor GluN2D subunit in the antidepressant effects of enantiomers of ketamine
- (2017) Soichiro Ide et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Antidepressant Potential of ( R )-Ketamine in Rodent Models: Comparison with ( S )-Ketamine
- (2017) Kenichi Fukumoto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit
- (2017) N Yao et al. MOLECULAR PSYCHIATRY
- Involvement of extracellular signal-regulated kinase (ERK) in the short and long-lasting antidepressant-like activity of NMDA receptor antagonists (zinc and Ro 25-6981) in the forced swim test in rats
- (2017) Bartłomiej Pochwat et al. NEUROPHARMACOLOGY
- Comparison of the Psychopharmacological Effects of Tiletamine and Ketamine in Rodents
- (2017) Piotr Popik et al. NEUROTOXICITY RESEARCH
- Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model
- (2017) Youge Qu et al. Scientific Reports
- Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior
- (2016) Rebecca A. Brachman et al. BIOLOGICAL PSYCHIATRY
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model
- (2016) Bangkun Yang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study
- (2016) M. Amidfar et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Habenula-Induced Inhibition of Midbrain Dopamine Neurons Is Diminished by Lesions of the Rostromedial Tegmental Nucleus
- (2016) P. Leon Brown et al. JOURNAL OF NEUROSCIENCE
- Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects
- (2016) G M I Chowdhury et al. MOLECULAR PSYCHIATRY
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures
- (2016) Ashley E. Lepack et al. NEUROPHARMACOLOGY
- Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study
- (2016) Gerard Sanacora et al. NEUROPSYCHOPHARMACOLOGY
- Rapid and sustained antidepressant properties of an NMDA antagonist/monoamine reuptake inhibitor identified via transporter-based virtual screening
- (2016) Jeffery N. Talbot et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Acute agmatine administration, similar to ketamine, reverses depressive-like behavior induced by chronic unpredictable stress in mice
- (2016) Vivian B. Neis et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test
- (2015) Phil Skolnick et al. ACTA NEUROPSYCHIATRICA
- Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders
- (2015) Y. Ohgi et al. CURRENT MOLECULAR MEDICINE
- Single-Dose Ketamine Followed by Daily d-Cycloserine in Treatment-Resistant Bipolar Depression
- (2015) Joshua T. Kantrowitz et al. JOURNAL OF CLINICAL PSYCHIATRY
- Concentration-Dependent Dual Mode of Zn Action at Serotonin 5-HT1A Receptors: In Vitro and In Vivo Studies
- (2015) Grzegorz Satała et al. MOLECULAR NEUROBIOLOGY
- Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor
- (2015) Kinga Sałat et al. NEUROPHARMACOLOGY
- Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc
- (2015) Bernadeta Szewczyk et al. NEUROPHARMACOLOGY
- Differential Effects of D-Cycloserine and ACBC at NMDA Receptors in the Rat Entorhinal Cortex Are Related to Efficacy at the Co-Agonist Binding Site
- (2015) Alex M. Lench et al. PLoS One
- Antidepressant-like effect of zinc is dependent on signaling pathways implicated in BDNF modulation
- (2015) Luana M. Manosso et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test
- (2015) Phil Skolnick et al. ACTA NEUROPSYCHIATRICA
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic
- (2014) Peter R Diamond et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?
- (2014) Gerard Sanacora et al. NEUROPSYCHOPHARMACOLOGY
- The Role of GluN2A and GluN2B Subunits on the Effects of NMDA Receptor Antagonists in Modeling Schizophrenia and Treating Refractory Depression
- (2014) Laura Jiménez-Sánchez et al. NEUROPSYCHOPHARMACOLOGY
- Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses
- (2014) E. S. Gideons et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013
- (2014) David A. Mrazek et al. PSYCHIATRIC SERVICES
- Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder
- (2014) Adriana Feder et al. JAMA Psychiatry
- Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression
- (2014) N Lally et al. Translational Psychiatry
- Inhibition of Glycine Transporter-I as a Novel Mechanism for the Treatment of Depression
- (2013) Chih-Chia Huang et al. BIOLOGICAL PSYCHIATRY
- Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings)
- (2013) Georges Mion et al. CNS Neuroscience & Therapeutics
- Antidepressant-like activity of magnesium in the chronic mild stress model in rats: alterations in the NMDA receptor subunits
- (2013) Bartłomiej Pochwat et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Antidepressant Augmentation Using theN-Methyl-d-Aspartate Antagonist Memantine
- (2013) Eric G. Smith et al. JOURNAL OF CLINICAL PSYCHIATRY
- Glycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male rats
- (2013) Wei-Li Zhu et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Serial infusions of low-dose ketamine for major depression
- (2013) Keith G Rasmussen et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects
- (2013) G Sanacora et al. MOLECULAR PSYCHIATRY
- mTORC1-dependent protein synthesis underlying rapid antidepressant effect requires GABABR signaling
- (2013) E.R. Workman et al. NEUROPHARMACOLOGY
- Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
- (2013) Carolyn I Rodriguez et al. NEUROPSYCHOPHARMACOLOGY
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- A randomized add-on trial of high-dose d-cycloserine for treatment-resistant depression
- (2012) Uriel Heresco-Levy et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
- (2012) Lobna Ibrahim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats
- (2012) Gislaine Z. Réus et al. METABOLIC BRAIN DISEASE
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal Cortex
- (2011) Rong-Jian Liu et al. BIOLOGICAL PSYCHIATRY
- Synaptic potentiation onto habenula neurons in the learned helplessness model of depression
- (2011) Bo Li et al. NATURE
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Possible antidepressant effects and mechanisms of memantine in behaviors and synaptic plasticity of a depression rat model
- (2011) M.-N. Quan et al. NEUROSCIENCE
- Translating Glutamate: From Pathophysiology to Treatment
- (2011) D. C. Javitt et al. Science Translational Medicine
- Structure of theMycobacterium tuberculosisd-Alanine:d-Alanine Ligase, a Target of the Antituberculosis Drug d-Cycloserine
- (2010) John B. Bruning et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Fluoxetine reverts chronic restraint stress-induced depression-like behaviour and increases neuropeptide Y and galanin expression in mice
- (2010) S.H. Christiansen et al. BEHAVIOURAL BRAIN RESEARCH
- Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
- (2010) Nancy DiazGranados et al. JOURNAL OF CLINICAL PSYCHIATRY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test
- (2009) B. Szewczyk et al. AMINO ACIDS
- Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
- (2009) Rebecca B. Price et al. BIOLOGICAL PSYCHIATRY
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Double-Blind, Randomized Comparison of Memantine and Escitalopram for the Treatment of Major Depressive Disorder Comorbid With Alcohol Dependence
- (2009) Leea H. Muhonen et al. JOURNAL OF CLINICAL PSYCHIATRY
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
- (2008) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Antidepressant-like activity of zinc: further behavioral and molecular evidence
- (2008) Magdalena Sowa-Kućma et al. JOURNAL OF NEURAL TRANSMISSION
- Rules of engagement for NMDA receptor subunits
- (2008) M. H. Ulbrich et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lack of persistent effects of ketamine in rodent models of depression
- (2008) Piotr Popik et al. PSYCHOPHARMACOLOGY
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now